| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2159830 | Radiotherapy and Oncology | 2009 | 8 Pages |
Abstract
Using the TCP model, the probability of tumor control is compromised following an incorrect choice of DtpL; so we conclude that the application of the F factor is an effective tool and clinical aid to derive the optimal reference dose level from the dose-volume histogram (DVH) of each treatment plan.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Antonella Bufacchi, Giorgio Arcangeli, Stefania delle Canne, Tiziana Malatesta, Roberto Capparella, Riccardo Fragomeni, Luca Marmiroli, Luisa Begnozzi,